Chinese Journal of Dermatology ›› 2023, Vol. 56 ›› Issue (3): 266-269.doi: 10.35541/cjd.20220924

• Reviews • Previous Articles     Next Articles

Research advances in systemic lupus erythematosus in 2022

Luo Shuaihantian1, Long Hai1, Lu Qianjin1,2,3   

  1. 1Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha 410011, China; 2Department of Dermatology, Hospital of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China; 3Key Laboratory of Immunological Dermatology and Translational Research, Chinese Academy of Medical Sciences, Nanjing 210042, China
  • Received:2022-12-29 Revised:2023-02-07 Online:2023-03-15 Published:2023-03-06
  • Contact: Lu Qianjin
  • Supported by:
    National Natural Science Foundation of China (81703133, 82273540, 81830097); Natural Science Foundation of Hunan Province of China (2021JJ40856); Hunan Science and Technology Innovation Project (2018RS3031); Changsha Science and Technology Planning Project (KQ1802002); Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2021-RC320-001, 2020-RC320-003); CAMS Innovation Fund for Medical Sciences (2021-I2M-1-059)

Abstract: 【Abstract】 Systemic lupus erythematosus has always been a research hotspot in the field of autoimmune diseases in China and other countries. In 2022, Chinese and international researchers have made a lot of new progress in epidemiology, pathogenesis, diagnosis and evaluation, and treatment of systemic lupus erythematosus. This review mainly summarizes major representative advances.

Key words: Lupus erythematosus, systemic, Diagnosis, Therapy, Incidence, Prevalence, Biological Agents, Biomarker